Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α

Ulcerative colitis (UC) is a complex inflammatory bowel disease (IBD) associated with mitochondrial function. Atractylenolide III (AT III) is a natural product with anti-inflammatory effects. The aim of this work is to investigate the protective effect of AT III on UC and its underlying mechanisms....

Full description

Saved in:
Bibliographic Details
Main Authors: Jieru Han, Wenhao Li, Guangyu Shi, Yunlei Huang, Xutao Sun, Na Sun, Deyou Jiang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/9129984
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558600149532672
author Jieru Han
Wenhao Li
Guangyu Shi
Yunlei Huang
Xutao Sun
Na Sun
Deyou Jiang
author_facet Jieru Han
Wenhao Li
Guangyu Shi
Yunlei Huang
Xutao Sun
Na Sun
Deyou Jiang
author_sort Jieru Han
collection DOAJ
description Ulcerative colitis (UC) is a complex inflammatory bowel disease (IBD) associated with mitochondrial function. Atractylenolide III (AT III) is a natural product with anti-inflammatory effects. The aim of this work is to investigate the protective effect of AT III on UC and its underlying mechanisms. Herein, dextran sulfate sodium- (DSS-) induced mice and lipopolysaccharide- (LPS-) stimulated intestinal epithelial cells (IEC-6) were employed to mimic UC pathologies in vivo and in vitro. The results showed that in DSS-induced mice, AT III significantly reversed the body weight loss, colon length reduction, disease activity index (DAI) increase, and histological damage. The production of proinflammatory factors and reduction of antioxidants in colitis were suppressed by AT III. In addition, we demonstrated that AT III attenuated the intestinal epithelial barrier destruction and mitochondrial dysfunction induced by DSS, which was similar to the in vitro results in LPS-treated IEC-6 cells. The protein levels of p-AMPK, SIRT1, and PGC-1α along with acetylated PGC-1α were also upregulated by AT III in vivo and in vitro. In conclusion, these findings support that AT III may protect against mitochondrial dysfunction by the activation of the AMPK/SIRT1/PGC-1α signaling pathway during UC development.
format Article
id doaj-art-7698565ab80440488c0de273fb50a3fa
institution Kabale University
issn 1466-1861
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-7698565ab80440488c0de273fb50a3fa2025-02-03T01:32:01ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/9129984Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1αJieru Han0Wenhao Li1Guangyu Shi2Yunlei Huang3Xutao Sun4Na Sun5Deyou Jiang6Department of Synopsis of the Golden ChamberDepartment of Synopsis of the Golden ChamberDepartment of Ultrasound MedicineFoundamental Training BaseDepartment of TyphoidSchool of Basic Medical SciencesDepartment of Synopsis of the Golden ChamberUlcerative colitis (UC) is a complex inflammatory bowel disease (IBD) associated with mitochondrial function. Atractylenolide III (AT III) is a natural product with anti-inflammatory effects. The aim of this work is to investigate the protective effect of AT III on UC and its underlying mechanisms. Herein, dextran sulfate sodium- (DSS-) induced mice and lipopolysaccharide- (LPS-) stimulated intestinal epithelial cells (IEC-6) were employed to mimic UC pathologies in vivo and in vitro. The results showed that in DSS-induced mice, AT III significantly reversed the body weight loss, colon length reduction, disease activity index (DAI) increase, and histological damage. The production of proinflammatory factors and reduction of antioxidants in colitis were suppressed by AT III. In addition, we demonstrated that AT III attenuated the intestinal epithelial barrier destruction and mitochondrial dysfunction induced by DSS, which was similar to the in vitro results in LPS-treated IEC-6 cells. The protein levels of p-AMPK, SIRT1, and PGC-1α along with acetylated PGC-1α were also upregulated by AT III in vivo and in vitro. In conclusion, these findings support that AT III may protect against mitochondrial dysfunction by the activation of the AMPK/SIRT1/PGC-1α signaling pathway during UC development.http://dx.doi.org/10.1155/2022/9129984
spellingShingle Jieru Han
Wenhao Li
Guangyu Shi
Yunlei Huang
Xutao Sun
Na Sun
Deyou Jiang
Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α
Mediators of Inflammation
title Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α
title_full Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α
title_fullStr Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α
title_full_unstemmed Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α
title_short Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α
title_sort atractylenolide iii improves mitochondrial function and protects against ulcerative colitis by activating ampk sirt1 pgc 1α
url http://dx.doi.org/10.1155/2022/9129984
work_keys_str_mv AT jieruhan atractylenolideiiiimprovesmitochondrialfunctionandprotectsagainstulcerativecolitisbyactivatingampksirt1pgc1a
AT wenhaoli atractylenolideiiiimprovesmitochondrialfunctionandprotectsagainstulcerativecolitisbyactivatingampksirt1pgc1a
AT guangyushi atractylenolideiiiimprovesmitochondrialfunctionandprotectsagainstulcerativecolitisbyactivatingampksirt1pgc1a
AT yunleihuang atractylenolideiiiimprovesmitochondrialfunctionandprotectsagainstulcerativecolitisbyactivatingampksirt1pgc1a
AT xutaosun atractylenolideiiiimprovesmitochondrialfunctionandprotectsagainstulcerativecolitisbyactivatingampksirt1pgc1a
AT nasun atractylenolideiiiimprovesmitochondrialfunctionandprotectsagainstulcerativecolitisbyactivatingampksirt1pgc1a
AT deyoujiang atractylenolideiiiimprovesmitochondrialfunctionandprotectsagainstulcerativecolitisbyactivatingampksirt1pgc1a